Senior insider sale
EVP, General Counsel, Corp Sec at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$33.1K
4.45K shares
What this filing means
DE VERNEUIL VANINA plans to sell 4.45K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $33.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/23/2026ACC: 0001959173-26-001354
Officer· EVP, General Counsel, Corp Sec
Since Feb 2026
4.45K
Shares to sell
$33.1K
Approx. market value
4.45K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/23/2026
4.45KTotal acquired4.45K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/23/2026 | Restricted Stock Vesting Compensation | 4.45K | — |
| Total | 4.45K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.45K
Market value
$33.1K
2/23/2026
Total
Units
4.45K
Value
$33.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/23/2026 | 4.45K | $33.1K | NASDAQ | Planned |
| Total | 4.45K | $33.1K | ||